Concentrix (CNXC) Cash & Equivalents (2020 - 2026)

Concentrix (CNXC) has 7 years of Cash & Equivalents data on file, last reported at $255.6 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 25.44% year-over-year to $255.6 million; the trailing twelve-month figure through May 2026 stood at $255.6 million (down 25.44% YoY), and the FY2025 full-year result was $327.3 million, up 36.07% from the prior year.
• Cash & Equivalents advanced to $255.6 million in Q2 2026, from $222.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.1 billion in Q3 2023 to a low of $142.2 million in Q1 2022.
• A 5-year average of $339.7 million and a median of $237.7 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 1099.89% in 2023 and plunged 88.35% in 2024, its largest moves.
• Tracing CNXC's Cash & Equivalents over 5 years: stood at $157.5 million in 2022, then soared by 87.56% to $295.3 million in 2023, then dropped by 18.54% to $240.6 million in 2024, then surged by 36.07% to $327.3 million in 2025, then dropped by 21.93% to $255.6 million in 2026.
• Business Quant data shows CNXC's Cash & Equivalents at $255.6 million in Q2 2026, $222.7 million in Q1 2026, and $327.3 million in Q4 2025.